Profilo
Sandeep C.
Kulkarni was the Chief Operating Officer at Immunovant, Inc. in 2018 and 2019.
Precedenti posizioni note di Sandeep C. Kulkarni
Società | Posizione | Fine |
---|---|---|
IMMUNOVANT, INC. | Chief Operating Officer | 01/12/2019 |
Immunovant, Inc. /Old/
Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Chief Operating Officer | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
IMMUNOVANT, INC. | Health Technology |
Aziende private | 1 |
---|---|
Immunovant, Inc. /Old/
Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Sandeep C. Kulkarni